Fien Loosveldt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fien Loosveldt has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Axelle Costenoble
Gerontology Department, Vrije Universiteit Brussel (VUB) , Laarbeeklaan 103, Brussels 1090
1 shared publication - Aziz Debain
Geriatrics Department, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium.
1 shared publication - Ivan Bautmans
Frailty & Resilience in Ageing (FRIA) Research Unit, Vitality Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium;b Gerontology Department, Vrije Universiteit Brussel (VUB), Brussels, Belgium;c Department of Geriatric Physiotherapy, SOMT University of Physiotherapy, The Netherlands;d Geriatrics Department, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
1 shared publication Jordy Saren
Frailty & Resilience in Ageing Research Unit, Vitality Research Group, Vrije Universiteit Brussel, Brussels, Belgium
1 shared publication- Mirko Petrovic
Section of Geriatrics, Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium
1 shared publication Veerle Knoop
Frailty & Resilience in Ageing Research Unit, Vitality Research Group, Vrije Universiteit Brussel, Brussels, Belgium
1 shared publication
Latest Publications
- 29 March 2025
- Published by Springer Nature in Drugs & Aging
- Vol. 42 (5) , 445-456
Symptoms of Orthostatic Hypotension and Drugs Affecting Autonomic Function are Associated with the Onset of Frailty in Community-Dwelling Persons Aged 80 Years and Above: A Prospective Observational Study
Background Both autonomic dysfunction and frailty are common and complex geriatric syndromes with similar negative health outcomes. Both conditions are characterized by a loss of homeostasis that makes individuals more vulnerable to stressors. Aim The primary aim of this study is to examine the association between drugs that affect autonomic function and frailty onset in community-dwelling octogenarians. The secondary aim is to investigate the relationship between autonomic dysfunction and frailty onset in this population. Methods In total, 372 nonfrail adults aged 80 years and above (mean age 83 ± 3 years) from the BUTTERFLY project were prospectively followed for 2 years (mean follow-up of 22 ± 6 months). The association between autonomic dysfunction (defined as neurogenic orthostatic hypotension and symptoms of orthostatic hypotension), the use of medications affecting autonomic function, and frailty status were examined using binary logistic regression analysis. Results The completely adjusted binary logistic regression model showed that the use of drugs affecting autonomic function was associated with frailty {adjusted odds ratio (aOR) = 1.78 [95% confidence interval (CI) 1.06–3.00], p = 0.030}. Furthermore, symptoms of orthostatic hypotension were related to frailty (aOR = 2.98 [95% CI 1.13–7.88], p = 0.027). Conclusions Our results show that symptoms of orthostatic hypotension and the use of drugs that affect autonomic function are accompanied with respectively 3-fold and 1.8-fold higher odds of frailty onset in persons aged 80 years and over. Therefore, pharmacological treatment that affects autonomic function should be started with caution and timely discontinued in older persons.
- 29 March 2025
- Published by Springer Nature in Drugs & Aging
- Vol. 42 (5) , 445-456
Symptoms of Orthostatic Hypotension and Drugs Affecting Autonomic Function are Associated with the Onset of Frailty in Community-Dwelling Persons Aged 80 Years and Above: A Prospective Observational Study
Background Both autonomic dysfunction and frailty are common and complex geriatric syndromes with similar negative health outcomes. Both conditions are characterized by a loss of homeostasis that makes individuals more vulnerable to stressors. Aim The primary aim of this study is to examine the association between drugs that affect autonomic function and frailty onset in community-dwelling octogenarians. The secondary aim is to investigate the relationship between autonomic dysfunction and frailty onset in this population. Methods In total, 372 nonfrail adults aged 80 years and above (mean age 83 ± 3 years) from the BUTTERFLY project were prospectively followed for 2 years (mean follow-up of 22 ± 6 months). The association between autonomic dysfunction (defined as neurogenic orthostatic hypotension and symptoms of orthostatic hypotension), the use of medications affecting autonomic function, and frailty status were examined using binary logistic regression analysis. Results The completely adjusted binary logistic regression model showed that the use of drugs affecting autonomic function was associated with frailty {adjusted odds ratio (aOR) = 1.78 [95% confidence interval (CI) 1.06–3.00], p = 0.030}. Furthermore, symptoms of orthostatic hypotension were related to frailty (aOR = 2.98 [95% CI 1.13–7.88], p = 0.027). Conclusions Our results show that symptoms of orthostatic hypotension and the use of drugs that affect autonomic function are accompanied with respectively 3-fold and 1.8-fold higher odds of frailty onset in persons aged 80 years and over. Therefore, pharmacological treatment that affects autonomic function should be started with caution and timely discontinued in older persons.